Document is current

Article History

Received: 3 November 2025

Accepted: 12 January 2026

First Online: 29 January 2026

Declarations

:

: All procedures were approved by the Project Authorisation Board of the Regional State Administrative Agency in Finland (license ESAVI/39801/2023). The license matches the requirements of both the European Union legislation and the updated ARRIVE 2.0 guidelines for reporting in vivo experiments. The animals were purpose-bred for laboratory research and purchased from Envigo RMS B.V. No separate consent to participate or permission to collect specimens/animals were required, since this was not a clinical study with privately-owned animals.

: Not applicable.

: The authors declare no competing interests.